Cargando…

Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: “real life” long-term outcome

BACKGROUND: To evaluate the long-term outcome of bevacizumab therapy for neovascular age related macular degeneration (NVAMD) in the setting of a clinic. METHODS: Consecutive group of NVAMD patients who were treated in a single 3(rd) referral center with bevacizumab using a loading dosage of 3 month...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beykin, Gala, Grunin, Michelle, Averbukh, Edward, Banin, Eyal, Hemo, Yitzchak, Chowers, Itay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404564/ https://www.ncbi.nlm.nih.gov/pubmed/25881145 http://dx.doi.org/10.1186/s12886-015-0019-x

Ejemplares similares

Socioeconomic status and visual outcome in patients with neovascular age-related macular degeneration
por: Levinger, Nadav, et al.
Publicado: (2020)

Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel
por: Chowers, Itay, et al.
Publicado: (2008)

Transcriptome Analysis on Monocytes from Patients with Neovascular Age-Related Macular Degeneration
por: Grunin, Michelle, et al.
Publicado: (2016)

Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular Degeneration
por: Rinsky, Batya, et al.
Publicado: (2021)

Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel
por: Chowers, Itay, et al.
Publicado: (2008)

Degeneration Modulates Retinal Response to Transient Exogenous Oxidative Injury
por: Lederman, Michal, et al.
Publicado: (2014)

Association of a Variant in VWA3A with Response to Anti-Vascular Endothelial Growth Factor Treatment in Neovascular AMD
por: Grunin, Michelle, et al.
Publicado: (2020)

Characterizing the effect of supplements on the phenotype of cultured macrophages from patients with age-related macular degeneration
por: Rinsky, Batya, et al.
Publicado: (2017)

CCR1 mediates Müller cell activation and photoreceptor cell death in macular and retinal degeneration
por: Elbaz-Hayoun, Sarah, et al.
Publicado: (2023)

Anti-tumor necrosis factor alpha reduces the proangiogenic effects of activated macrophages derived from patients with age-related macular degeneration
por: Hagbi-Levi, Shira, et al.
Publicado: (2021)

Evaluation of antioxidant treatments for the modulation of macrophage function in the context of retinal degeneration
por: Elbaz-Hayoun, Sarah, et al.
Publicado: (2019)

Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema
por: Hanhart, Joel, et al.
Publicado: (2015)

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2008)

Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Non-Age-Related Macular Degeneration
por: Salehipour, Masoud, et al.
Publicado: (2010)

Monthly Alternating Injections of Aflibercept and Bevacizumab for Neovascular Age-Related Macular Degeneration
por: Lee, Junyeop, et al.
Publicado: (2022)

Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment
por: Hagbi-Levi, Shira, et al.
Publicado: (2019)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2010)

Is monthly retreatment with intravitreal bevacizumab (Avastin(®)) necessary in neovascular age-related macular degeneration?
por: Ghazi, Nicola G, et al.
Publicado: (2010)

Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
por: Fang, Kai, et al.
Publicado: (2013)

The Role of Epiretinal Membrane on Treatment of Neovascular Age-Related Macular Degeneration with Intravitreal Bevacizumab
por: Alkin, Zeynep, et al.
Publicado: (2013)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
por: Torabi, Hamidreza, et al.
Publicado: (2018)

Clinical outcome using a modified treat-and-extend protocol for neovascular age-related macular degeneration
por: Vofo, Brice Nguedia, et al.
Publicado: (2022)

Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
por: Kim, Hyun Woong, et al.
Publicado: (2011)

The effect of intravitreal bevacizumab (Avastin(®)) on ocular pulse amplitude in neovascular age-related macular degeneration
por: Rechtman, Ehud, et al.
Publicado: (2011)

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab
por: Damkondwar, Deepali R, et al.
Publicado: (2022)

Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate
por: Vofo, Brice Nguedia, et al.
Publicado: (2023)

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
por: Ahmadieh, Hamid, et al.
Publicado: (2007)

Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
por: Biswas, Partha, et al.
Publicado: (2011)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
por: Nourinia, Ramin, et al.
Publicado: (2010)

Multifocal Electroretinogram Findings after Intravitreal Bevacizumab Injection in Choroidal Neovascularization of Age-Related Macular Degeneration
por: Park, Joo Youn, et al.
Publicado: (2011)

Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal Neovascularization Associated with Age-related Macular Degeneration
por: Modarreszadeh, Mehdi, et al.
Publicado: (2008)

Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials
por: Kodjikian, Laurent, et al.
Publicado: (2014)

Bevacizumab versus Ranibizumab on As-Needed Treatment Regimen for Neovascular Age-Related Macular Degeneration in Turkish Patients
por: Ozkaya, Abdullah, et al.
Publicado: (2013)

Safety and clinical effectiveness of intravitreal administration of bevacizumab (Lumiere(®)) in patients with neovascular age-related macular degeneration
por: Benisek, Daniel A., et al.
Publicado: (2020)

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
por: Wang, Zongyi, et al.
Publicado: (2020)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
por: Griffin, David R., et al.
Publicado: (2014)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment
por: Khan, Adnan H., et al.
Publicado: (2023)

Influence of unilateral intravitreal bevacizumab injection on the incidence of symptomatic choroidal neovascularization in the fellow eye in patients with neovascular age-related macular degeneration (Review)
por: Branisteanu, Daniel Constantin, et al.
Publicado: (2020)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Kabeel, Mamdouh M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_f37i7agv52mp8pckqtgsrcj4n4